OMER Q4 2024 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$835M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$301,000

Operating Income

-$36M

Net Income

-$31M

EPS (Diluted)

$-0.54

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$29M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$277M

Total Liabilities

$460M

Stockholders' Equity

-$183M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$301,000	-$205,000	-46.8%
Operating Income	-$36M	-$40M	+10.3%
Net Income	-$31M	-$9M	-245.8%